Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-26

FDA Approved: DEFERASIROX — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved a supplemental application for Deferasirox submitted by Amneal Pharmaceuticals NY LLC. The supplemental filing updates the approved product wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferasirox (Deferasirox)

Snippet

SUPPL AP for DEFERASIROX (DEFERASIROX)